DRG International DRG:Hybrid-XL® to Dazzle at 2014 AACC
2014 AACC Annual Meeting Press ProgramThe DRG:Hybrid-XL® will be showcased as the centerpiece of DRG International’s display at the 2014 AACC conference in Chicago, IL.
The DRG:Hybrid-XL® will be showcased as the centerpiece of DRG International’s display at the 2014 AACC conference in Chicago, IL.
DRG International, a leading international medical diagnostic company, will showcase its DRG Hepcidin 25 (bioactive) ELISA Kit (EIA-5258) at the 2014 AACC in Chicago, IL from July 27-31.
DRG International, a leading international medical diagnostic company, will showcase its DRG Aldosterone ELISA Kit at the 2014 AACC in Chicago, IL from July 27-31.
Diazyme Laboratories today announced that the U.S. Food and Drug Administration (FDA) has granted 510(K) clearance to market its Vitamin D assay for Clinical Chemistry Analyzers.
COLA, the largest private accreditor of medical laboratories serving more than 8,000 across the U.S., successfully concluded its 2014 Leadership Summit in April.
The nation’s healthcare system -- and with it, the laboratory community – is undergoing a period of tremendous change as The Affordable Care Act begins implementation and new healthcare delivery models such as The Patient-Centered Medical Home (PCMH) and Accountable Care Organizations (ACOs) proliferate.
COLA Inc., based in Columbia, MD, an independent, nonprofit laboratory CLIA-accreditation organization, accrediting more than 7,000 clinical diagnostic labs on July, 2013, launched a new education subsidiary, COLA Resources Inc. (CRI®), whose mission is to “Provide educational & consultative services aimed at improving laboratory medicine and patient care.”
As a leading educator in laboratory medicine, COLA Resources Inc.’s (CRI®) goal is to continually update our education platform to reflect and support education regarding changes in regulatory requirements.
Attending the CRI® Symposium for Clinical Laboratories, affords participants the opportunity to participate in discussions centered on EDUCATION FOR LABORATORY EXCELLENCE – making a positive impact for quality patient care. This year’s symposium will be held October 15-18, 2014 at the Buena Vista Palace Hotel & Spa Lake Buena Vista (Orlando), FL. Participants can attend a wide selection of educational sessions, earn up to 20 CME or P.A.C.E® credits, network with other healthcare professionals and visit the exhibit hall featuring the latest laboratory technology, equipment and supplies.
The DRG 25-OH Vitamin D (total) ELISA, an enzyme immunoassay for the measurement of total 25-OH Vitamin D (Vitamin D2 and Vitamin D3) in both serum and plasma, will be a highlight of the 2014 American Association for Clinical Chemistry (AACC) Conference.
DRG International’s Renin (Active) ELISA for testing of active Renin in human EDTA plasma will be on display at the AACC’s 2014 show in Chicago, IL on July 27-31.
As a leading manufacturer of raw material for IVD industry, Fapon Biotech Inc. discovers, develops and provides innovative antigen, antibodies and enzymes that deliver significant benefits to IVD industry.
University Hospitals (UH) Case Medical Center has signed an agreement with ARUP Laboratories, a major national clinical reference laboratory which will include in its menu of tests an HIV diagnostic test invented at the UH Translational Laboratory by Miguel Quinones-Mateu, PhD.
An article in the London Times reviews the brain function beverage market, consumer demand, the leading drinks and their ingredients.
As a global first, a new platform, www.medicinno.com, aims to bring together doctors and pharmacists to share their professional opinions and expertise, as well as stay abreast of the latest developments in the health sciences.
The Intelligent Healthcare Association (IHA), in a partnership with ASHP (American Society of Health-System Pharmacists), is excited to introduce the first-ever Intelligent Pharmacy Pavilion (IPP) at ASHP’s 2014 Midyear Clinical Meeting and Exhibition in Anaheim, CA, December 7-11.
The thyroid calculator for rapid calculation of: Calcitonin and Carcinoembryonic Antigen Doubling Time; Thyroid Nodule Volume change; Thyroid Cancer Staging. Calculation results are not preserved within the app, thus maintaining patient privacy and security.
AdhereTech and The University of Alabama in Huntsville (UAH) have been awarded a second U.S. patent for a smart pill bottle invented at UAH that automatically measures if patients have taken their medication.
The American Academy of Dermatology (Academy) is pleased to announce Bristol-Myers Squibb’s donation of its Melanoma Exposed™ program to the Academy. The donation, provided through a charitable grant, will be used to increase public awareness of skin cancer – including melanoma, the deadliest form of skin cancer – and expand the number of free skin cancer screenings across the country through the Academy’s SPOT Skin Cancer™ initiative. Bristol-Myers Squibb’s donation of Melanoma Exposed™ includes a five-year contribution to the Academy, totaling more than $4 million.
The Uniform Application makes it easier for physicians to become licensed in multiple states by providing a “core” application used by the 23 state medical boards using the UA. It eliminates the need for physicians to re-enter data multiple times and makes it easier for physicians to apply for licensure in multiple states.
The Office of the Vice President for Research at Wayne State University announced today the finalization of a license agreement with a new start-up company, Detroit Materials, Inc., for a Wayne State University patented portfolio of high-strength low-alloy steels and cast irons for demanding applications in the defense, off-highway, tooling and automotive industries.
DaVinci Biosciences, LLC announced today that their paper on "Human Prenatal Intestine Cells as a Valuable Source of Stem Cells and Epithelial Cells; Phenotypic and Functional Characterization" has been accepted for publication in the peer-reviewed journal CELL & TISSUE TRANSPLANTATION & THERAPY.
Protea Biosciences Group, Inc. (OTCQB:PRGB) announced it has entered into a research collaboration with the University of Southampton, a leading biomedical and clinical research institution located in the United Kingdom. The collaboration will partner Protea’s proprietary direct molecular imaging technology and capabilities with a team of Alzheimer’s researchers at the University of Southampton, to study the molecular mechanisms of the aged brain, in order to identify markers that may indicate risk of developing Alzheimer’s disease.
Amway has extended its exclusive research partnership with Yale University through 2016, adding an additional three years to the original agreement. Doubling the length of this collaboration enables Amway scientists and Yale Lab Associate and Research Faculty Member Dr. John Pawelek to continue advancing their collective understanding of the molecular biology involved in skin pigmentation – specifically hyperpigmented spots. Understanding the pathways involved enables the development of more effective, more targeted treatments. Findings will fuel breakthrough products in the Artistry Ideal Radiance™ Collection targeting skin brightening.
A decades-long partnership between Sandia National Laboratories and the Norwegian research organization SINTEF (Stiftelsen for industriell og teknisk forskning) will now tackle energy challenges such as renewable energy integration, electric grid modernization, gas technologies and algae-based biofuels, under an expanded agreement.
Studying increases in yield important to understanding how food and fiber needs will be met in the future
Ablative Solutions, Inc. (ASI), a privately held company headquartered in Kalamazoo, MI, with offices in Menlo Park, CA, announced today that it has added Paul Sobotka, MD, FACP, FACC, FAHA, a highly respected clinician, to its Scientific Advisory Board. The Company is developing a patented device for sympathetic nerve modulation, the Peregrine System™, which delivers treatment to the outer region of arteries, including renal arteries, where the sympathetic nerves are located. The interruption of these nerve pathways may have therapeutic implications for hypertension, metabolic syndrome, congestive heart failure and obesity.
A new partnership between Case Western Reserve University and Intwine Connect LLC represents a fresh twist to how ideas developed by university researchers are brought to the commercial market. The agreement has been arranged through Case Western Reserve’s Technology Transfer Office, which helps faculty and student researchers turn inventions and other intellectual property into commercial ventures.
Folio Photonics LLC, a start-up company spun off from research in the Center for Layered Polymer Systems at Case Western Reserve University, has received an exclusive license from the university to commercialize products for a large and evolving archival optical data storage market.
Roswell Park Cancer Institute collaborated with biophotonics manufacturer Zenalux Biomedical to produce an enhanced spectrographic system for improved early detection of oral cancers.
MMIS is a global technology company providing compliance and business intelligence solutions for the life science industry. The MediSpend® Global Compliance SaaS solution was developed using a proprietary rules-based system with tremendous flexibility and update speed. MediSpend® solves the need for companies to aggregate spend tracking and reporting. MediSpend® incorporates master data management (MDM) with a workflow designed to automate data entry from enterprise source systems and transforms data into reports required for state, federal and global jurisdictions.
/PRNewswire/ -- The world of laboratory animal handling just became a great deal safer thanks to an ergonomically designed biological cabinet design from NuAire. These next-generation units have already received approval from the NSF (National Sanitation Foundation) and are ANSI 49 Listed.
The Scripps Research Institute (TSRI) today announced the formation of Scripps Advance, a new drug discovery initiative to translate early-stage biomedical research projects, both internal and external to TSRI, into clinical development candidates. Scripps Advance’s first collaborator in this new endeavor is the Johnson & Johnson Innovation Center in California.
Sunstar Inc., a Switzerland-based, leading company in oral health care and one of the first businesses to emphasize an integrated approach to the relationship between oral health and systemic disease, and Joslin Diabetes Center, the world's largest diabetes research and clinical care organization dedicated to the prevention, treatment and cure of diabetes, have renewed their commitment to the Joslin Sunstar Diabetes Education Initiative (JSDEI).
The American Society of Anesthesiologists (ASA) today announced it has chosen Premier, Inc. (NASDAQ: PINC), a leading health care improvement company, to develop a first-of-its-kind learning collaborative for the ASA’s Perioperative Surgical Home (PSH) model of care.
Ablative Solutions, Inc., a privately-held clinical stage company, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Peregrine System(TM) Infusion Catheter.
Sandia National Laboratories will bring decades of experience solving problems with practical engineering and modeling complex systems to cities around the world under a new agreement to support the 100 Resilient Cities Centennial Challenge, pioneered by the Rockefeller Foundation.
HylaPharm's patented technology delivers chemotherapy drugs directly to cancer cells in tumors and nearby lymph nodes while limiting drug exposure in kidneys, nerves and auditory organs.
An Internet search engine developed specifically for use in schools by two University of Alabama in Huntsville (UAH) professors has received $35,000 from Alabama Launchpad, the largest award received in this round.
The three Kole brain function drinks - Alive, Happy and Dreams -are now available for purchase through Amazon.com.
MMIS, a leading provider of SaaS compliance solutions for the life science industry, introduces MediSpend® Validate, an easy-to-use, self-service tool, designed to help pharmaceutical and medical device companies validate all three Federal Open Payment Reports. MediSpend® Validate fills the gap in the current transparency process.
Pedigrees are diagrams showing how inherited diseases may occur in a particular family. A new app now lets healthcare providers create pedigrees digitally with few finger taps during a face-to-face patient encounter.
Representatives from national labs, universities and business will gather for a Cleantech Open Business Briefing on March 18 at Sandia National Laboratories’ Livermore Valley Open Campus (LVOC) to highlight how those entities are working together to develop clean technologies and take them into the marketplace.
Oak Ridge National Laboratory partnering with Cincinnati Incorporated to develop a large-scale polymer additive manufacturing (3-D printing) system.
MMIS, a leading provider of SaaS compliance solutions for the life science industry, introduces MediSpend® Validate, an easy-to-use, self-service tool, designed to help pharmaceutical and medical device companies validate all three Federal Open Payment Reports. MediSpend® Validate fills the gap in the current transparency process.
February 5 — JoVE, the Journal of Visualized Experiments, has just released the third collection of its vastly popular Science Education video series in three additional languages—Chinese, Japanese and French. The collection, Model Organisms I: yeast, Drosophila and C. elegans, kicks off JoVE’s decision to make its entire Science Education video database available to those scientists, especially students, for whom English—the most commonly used language in scientific literature— is not their first language.
Ablative Solutions, Inc., a privately-held clinical stage company headquartered in Kalamazoo, MI, with offices in Menlo Park, CA, announced today that it has completed a Series B Preferred Stock financing, totaling approximately $9.5 million (including the conversion of the bridge financing completed in 2013), to fund its unique technology platform for renal denervation. The round was led by BioStar Ventures and Michigan Accelerator Fund, and included participation by the founders and multiple angel investors. "The Company has made tremendous progress in the two years since its inception with a unique approach to renal denervation, and has done so with great capital efficiency," affirmed Dale Grogan of Michigan Accelerator Fund, who was elected to the Company's Board of Directors upon closing of the financing.
/PRNewswire/ -- Altheus Therapeutics, Inc. announced the USPTO has allowed patent 8,629,127 B2 covering the oral pharmaceutical composition 5-ASA (5-aminosalicylic acid) and NAC (N-acetylcysteine). Combination therapy patents are uncommon and under-appreciated in the pharmaceutical industry because the Patent Office requires surprising, unexpected, or synergistic benefits from combining active ingredients into a single formulation. Altheus' success in procuring the strong and diverse patents for Zoenasa, including this most recent oral combination therapy patent, stems from rigorous studies demonstrating highly statistically significant synergy between Zoenasa's two components.
The International Anesthesia Research Society (IARS) announces that its educational initiative OpenAnesthesia (OA) has released version 2.0 of its self-study app for anesthesiology residents, CRNAs, SRNAs and physicians. A new set of 150 review questions has been added, for in-app purchase, for a total of 351 questions. The app is free to download on iTunes here.
Last week, JoVE, the Journal of Visualized Experiments, introduced a web application allowing scientists to view their text-based scientific articles in a 21st century format.